1. Home
  2. /
  3. Investments
  4. /
  5. Broken String Biosciences

Broken String Biosciences

Developer of a sequencing platform intended to drive the development of cell and gene therapies that are safer by design. The company's platform combines novel sequencing techniques, bioinformatics analysis, and artificial intelligence, providing healthcare professionals with a data-driven approach to safely introduce the next generation of innovative medicines, including cells and gene therapies.

Team

Venture Capital

Status

Current

Geography

Europe

Financing Round

Financing round - Series A

Segment

Life Science Tools

Entry Date

2023

Key Figures

Current

Status

2020

Creation Date

21

Number of Employees

2023

Investment Date

OMX Europe Venture Fund

Fund Name

Key Contacts

Related companies